HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 6,661-6,672 of 27,277
Other study type icon
Active Not RecruitingNCT05310695

A Multicentre Controlled study of the Norwegian Health in Work Service. The NSAC Efficacy Study

Official study title

A Multicentre Randomised Controlled Trial of the Norwegian Health in Work Service for Patients With Common Mental Disorders and Musculoskeletal Disorders: The Norwegian Sickness Absence Clinic (NSAC) Efficacy Study

This study is no longer accepting new participants.

Multiple locations, including Bodø
Anxiety, DepressionInterventional studyAges 18+
Countries
Norway
Sponsor
Nordlandssykehuset HF
Drug study icon
CompletedEUCTR 2020-001348-25

A multicentre study to assess safety and efficacy of psilocybin in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
DepressionHistorical research record
Countries
Czechia, Denmark, Germany, + 2 others
Sponsor
COMPASS Pathways, Ltd
Drug study icon
CompletedEUCTR 2017-004602-17

A Multicentre, 8-week, Single-arm, Open-label, Pragmatic Trial to Explore Acceptance and Performance of Using a Digital Medicine System with Healthcare Professionals and Adult Subjects with Schizo...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In United Kingdom
SchizophreniaHistorical research record
Countries
United Kingdom
Sponsor
Otsuka Pharmaceutical
Drug study icon
CompletedEUCTR 2018-001963-22

A multicentre, double-blind, randomised, placebo - controlled phase II study to assess efficacy, safety and pharmacokinetics of inhaled Esketamine in subject with treatment-resistant depression in ...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Poland
Depression, BipolarityHistorical research record
Countries
Poland
Sponsor
Celon Pharma SA
Drug study icon
CompletedEUCTR 2018-002669-20

A multicentre, double-blind, randomised, placebo - controlled phase II study to assess efficacy, safety and pharmacokinetics of inhaled Esketamine in subjects with treatment-resistant bipolar depre...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Poland
Bipolarity, DepressionHistorical research record
Countries
Poland
Sponsor
Celon Pharma SA
Drug study icon
CompletedACTRN12618001048279

Safety study of R-107 in depression

Official study title

A Multicentre, Open-Label, Phase 2 Safety Extension Study to Evaluate the Safety and Tolerability of R-107 in subjects with Refractory Major Depressive Disorder.

This study has finished and is no longer accepting participants.

Multiple locations, including Southport
DepressionInterventional studyAges 18–81
Countries
Australia, New Zealand
Sponsor
Douglas Pharmaceuticals Ltd.
Drug study icon
CompletedEUCTR 2004-000730-37

A multicentre, randomised, double-blind, placebo-controlled, parallel group, dose-response phase III A study to evaluate safety and efficacy of Prolonged Release (PR) OROS methylphenidate (18, 36 a...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
ADHDHistorical research record
Countries
Czechia, Denmark, Finland, + 1 other
Sponsor
Janssen-Cilag Medical Affairs EMEA
Behavioral study icon
CompletedNCT03126526

A Multimodal Outcome Study of Eating disorders

Official study title

Targeting Top-down and Bottom-up Processing in Eating Disorders Using Computerized Training Approaches: A Multimodal Outcome Study

This study has finished and is no longer accepting participants.

In London
Eating disordersBehavioural studyAges 18–60
Countries
United Kingdom
Sponsor
King's College London (University)
Drug study icon
CompletedEUCTR 2022-001865-11

A Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study with an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy, Safety, and Tolerability of Ola...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
SchizophreniaHistorical research record
Countries
Bulgaria
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Drug study icon
CompletedEUCTR 2010-022257-41

A Multinational, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Assess the Efficacy and Safety of Lu AA21004 in Patients with Major Depressive Disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Finland
DepressionHistorical research record
Countries
Finland, Germany, Latvia, + 1 other
Sponsor
Takeda Global Research and Development Centre (Europe) Ltd.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.